Clinical Trials Browser

NETWORK × Carcinoma, Renal Cell × Gefitinib × Clear all

NCT00467077 2017-03-17

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 2 Terminated

21 enrolled 8 charts

Carcinoma, Renal Cell, Kidney Neoplasms